1887

Abstract

Increasing numbers of carbapenemase-producing (CPE), which can be challenging to treat, have been referred to the national reference laboratory in England since the early 2000s.

Previous studies on CPE in the UK have focussed on localized outbreaks. We applied whole-genome sequencing (WGS) to isolates referred to the national reference laboratory over 30 months to inform our understanding of CPE epidemiology in England.

The first confirmed CPE from each new patient referred by an English diagnostic laboratory between 1 January 2014 and 30 June 2016 was sequenced on an Illumina HiSeq 2500. Multiple isolates from the same patient were included from either different species or the same species with different carbapenemase genes. The data were analysed using an in-house bioinformatics pipeline that determines species identification, multi-locus sequence typing (MLST) profile and antimicrobial resistance gene content.

A total of 2658 non-duplicate CPE were sequenced amongst which three host organisms belonging to diverse sequence types (STs) predominated: (1380/2658, 51.9 %; 177 STs), (723/2658, 27.2 %; 133 STs) and (294/2658, 11.1 %; 88 STs). Thirty different carbapenemase gene variants were identified, although (1122/2658, 42.2%), (692/2658, 26.0 %), (571/2658, 21.5 %), (100/2658, 3.8 %) and (33/2658, 1.2 %) predominated. ST/carbapenemase gene pairings represented widely distributed high-risk clones or clusters at a regional or hospital level.

CPE referred to the national reference laboratory are diverse, suggesting multiple introductions to England and a role for horizontal transfer of carbapenemase genes in English CPE epidemiology.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001518
2022-05-23
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/71/5/jmm001518.html?itemId=/content/journal/jmm/10.1099/jmm.0.001518&mimeType=html&fmt=ahah

References

  1. Otter JA, Burgess P, Davies F, Mookerjee S, Singleton J et al. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. Clin Microbiol Infect 2017; 23:188–196 [View Article] [PubMed]
    [Google Scholar]
  2. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35:736–755 [View Article] [PubMed]
    [Google Scholar]
  3. Mathers AJ, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev 2015; 28:565–591 [View Article] [PubMed]
    [Google Scholar]
  4. Livermore DM, Woodford N. Carbapenemases: a problem in waiting?. Curr Opin Microbiol 2000; 3:489–495 [View Article] [PubMed]
    [Google Scholar]
  5. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18:413–431 [View Article] [PubMed]
    [Google Scholar]
  6. Public Health England UK Standards for Microbiological Investigations. Detection of bacteria with carbapenem-hydrolysing beta-lactamases (carbapenemases); 2020 https://www.gov.uk/government/publications/smi-b-60-detection-of-bacteria-with-carbapenem-hydrolysing-lactamases-carbapenemases
  7. Public Health England Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae; 2020 https://www.gov.uk/government/publications/carbapenemase-producing-enterobacteriaceae-early-detection-management-and-control-toolkit-for-acute-trusts
  8. Brolund A, Lagerqvist N, Byfors S, Struelens MJ, Monnet DL et al. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018. Euro Surveill 2019; 24: [View Article] [PubMed]
    [Google Scholar]
  9. Doumith M, Findlay J, Hirani H, Hopkins KL, Livermore DM et al. Major role of pKpQIL-like plasmids in the early dissemination of KPC-type carbapenemases in the UK. J Antimicrob Chemother 2017; 72:2241–2248 [View Article] [PubMed]
    [Google Scholar]
  10. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 2014; 30:2114–2120 [View Article] [PubMed]
    [Google Scholar]
  11. Tewolde R, Dallman T, Schaefer U, Sheppard CL, Ashton P et al. MOST: a modified MLST typing tool based on short read sequencing. PeerJ 2016; 4:e2308 [View Article] [PubMed]
    [Google Scholar]
  12. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9:357–359 [View Article] [PubMed]
    [Google Scholar]
  13. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al. The sequence alignment/map format and SAMtools. Bioinformatics 2009; 25:2078–2079 [View Article] [PubMed]
    [Google Scholar]
  14. UK Health Security Agency English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) Report 2020 to 2021; 2021 https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report
  15. Freeman R, Ironmonger D, Hopkins KL, Puleston R, Staves P et al. Epidemiology of carbapenemase-producing Enterobacterales in England, May 2015-March 2019: national enhanced surveillance findings and approach. Infect Prev Pract 2020; 2:100051 [View Article]
    [Google Scholar]
  16. Dortet L, Cuzon G, Ponties V, Nordmann P. Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014. Euro Surveill 2017; 22:30461 [View Article]
    [Google Scholar]
  17. van der Zwaluw K, Witteveen S, Wielders L, van Santen M, Landman F et al. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance. Clin Microbiol Infect 2020; 26:1412 [View Article]
    [Google Scholar]
  18. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019; 19:56–66 [View Article]
    [Google Scholar]
  19. Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 2017; 17:153–163 [View Article]
    [Google Scholar]
  20. Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL et al. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill 2015; 20: [View Article]
    [Google Scholar]
  21. Meunier D, Findlay J, Doumith M, Godoy D, Perry C et al. FRI-2 carbapenemase-producing Enterobacter cloacae complex in the UK. J Antimicrob Chemother 2017; 72:2478–2482 [View Article] [PubMed]
    [Google Scholar]
  22. Ellington MJ, Davies F, Jauneikaite E, Hopkins KL, Turton JF et al. A multispecies cluster of GES-5 carbapenemase-producing Enterobacterales linked by a geographically disseminated plasmid. Clin Infect Dis 2020; 71:2553–2560 [View Article] [PubMed]
    [Google Scholar]
  23. Otter JA, Doumith M, Davies F, Mookerjee S, Dyakova E et al. Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London. Sci Rep 2017; 7:12711 [View Article] [PubMed]
    [Google Scholar]
  24. Donker T, Henderson KL, Hopkins KL, Dodgson AR, Thomas S et al. The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England. BMC Med 2017; 15:86 [View Article] [PubMed]
    [Google Scholar]
  25. David S, Reuter S, Harris SR, Glasner C, Feltwell T et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol 2019; 4:1919–1929 [View Article] [PubMed]
    [Google Scholar]
  26. Ellaby N, Doumith M, Hopkins KL, Woodford N, Ellington MJ. Emergence of diversity in carbapenemase-producing Escherichia coli ST131, England, January 2014 to June 2016. Euro Surveill 2019; 24:1800627 [View Article]
    [Google Scholar]
  27. Stoesser N, Sheppard AE, Peirano G, Anson LW, Pankhurst L et al. Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli. Sci Rep 2017; 7:5917 [View Article] [PubMed]
    [Google Scholar]
  28. Potron A, Poirel L, Rondinaud E, Nordmann P. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill 2013; 18:20549 [View Article] [PubMed]
    [Google Scholar]
  29. European Centre for Disease Prevention and Control Rapid risk assessment: Increase in OXA -244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013; 2020 https://www.ecdc.europa.eu/sites/default/files/documents/RRA-E-coli-OXA-244-producing-E-coli-EU-EEA-UK-since-2013.pdf
  30. Roer L, Overballe-Petersen S, Hansen F, Schønning K, Wang M et al. Escherichia coli sequence type 410 is causing new international high-risk clones. mSphere 2018; 3:e00337-18 [View Article] [PubMed]
    [Google Scholar]
  31. Wu W, Feng Y, Tang G, Qiao F, McNally A et al. NDM metallo-β-lactamases and their bacterial producers in health care settings. Clin Microbiol Rev 2019; 32:e00115-18 [View Article] [PubMed]
    [Google Scholar]
  32. Takayama Y, Sekizuka T, Matsui H, Adachi Y, Eda R et al. Characterization of the IncFII-IncFIB (pB171) plasmid carrying blaNDM-5 in Escherichia coli ST405 clinical isolate in Japan. Infect Drug Resist 2020; 13:561–566 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001518
Loading
/content/journal/jmm/10.1099/jmm.0.001518
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error